title: Treacher-Collins syndrome and co-existing dermatomyositis.
abstract: BACKGROUND
  Treacher-Collins syndrome, an autosomal dominantly inherited malformation of structures derived from the first and second branchial arch, has an incidence of 1:10,000 newborns. The prevalence of dermatomyositis at less than 24 years of age has been estimated at 1 per 100,000. The occurrence of both Treacher-Collins syndrome and dermatomyositis combined in the same patient should occur once in every 1,000,000,000 subjects.
  
  
  METHODS
  We report a patient with Treacher-Collins syndrome who developed dermatomyositis at the age of 5 years.
  
  
  RESULTS
  No other patient with both Treacher-Collins syndrome and an autoimmune disease has been reported. The thymus originates from the third branchial pouch and is unaffected by the syndrome. In Treacher-Collins syndrome the affected gene has been mapped to the fifth chromosome, while dermatomyositis is related to HLA B8 and DR3, coded on the sixth chromosome. No immunologic alteration has been described in patients with Treacher-Collins syndrome.
  
  
  CONCLUSIONS
  This is the first report of a patient with Treacher-Collins syndrome and dermatomyositis. There is no genetic or physiopathologic explanation for the concurrence of both conditions.
authors.affiliation: Instituto Nacional de Pediatria, Mexico City, Mexico.
authors.forename: D E
authors.initials: DE
authors.lastname: Larenas-Linnemann
authors.forename: R
authors.initials: R
authors.lastname: Berrón-Perez
authors.forename: J A
authors.initials: JA
authors.lastname: Ortega-Martell
authors.forename: E
authors.initials: E
authors.lastname: Onuma-Takane
authors.forename: Z
authors.initials: Z
authors.lastname: Huicochea-Grobet
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002675:Child, Preschool; D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D004077:Digoxin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008342:Mandibulofacial Dysostosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D012867:Skin / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002316:Cardiotonic Agents; D004077:Digoxin; D001241:Aspirin; D011241:Prednisone